GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma.
Avilés, A
GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma. [electronic resource] - Leukemia & lymphoma Apr 1995 - 327-30 p. digital
Publication Type: Clinical Trial; Journal Article
1042-8194
10.3109/10428199509056839 doi
Adult
Aged
Agranulocytosis--chemically induced
Bone Marrow Transplantation
Combined Modality Therapy
Cyclophosphamide--adverse effects
Dose-Response Relationship, Drug
Female
Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects
Hematopoietic Stem Cell Transplantation
Humans
Infusions, Intravenous
Lymphoma, Non-Hodgkin--blood
Male
Middle Aged
Pilot Projects
Platelet Transfusion
Prognosis
GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma. [electronic resource] - Leukemia & lymphoma Apr 1995 - 327-30 p. digital
Publication Type: Clinical Trial; Journal Article
1042-8194
10.3109/10428199509056839 doi
Adult
Aged
Agranulocytosis--chemically induced
Bone Marrow Transplantation
Combined Modality Therapy
Cyclophosphamide--adverse effects
Dose-Response Relationship, Drug
Female
Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects
Hematopoietic Stem Cell Transplantation
Humans
Infusions, Intravenous
Lymphoma, Non-Hodgkin--blood
Male
Middle Aged
Pilot Projects
Platelet Transfusion
Prognosis